Overview
Carcinoma of the sublingual gland is a rare malignancy that often presents with nonspecific symptoms, complicating early diagnosis and management. Typically, patients may initially present with swelling in the floor of the mouth, which can mimic benign conditions such as sublingual ranula or benign enlargement. This swelling can significantly impact quality of life and complicate procedures such as dental implantation and rehabilitation. Given its rarity, clinical suspicion and thorough diagnostic evaluation are crucial for timely intervention and optimal outcomes. The management strategies range from minimally invasive techniques like sclerotherapy to surgical excision, each with its own set of advantages and potential complications. Understanding the nuances of presentation, diagnosis, and treatment is essential for clinicians managing these cases effectively.
Clinical Presentation
Patients with carcinoma of the sublingual gland often present with swelling in the floor of the mouth, which can be unilateral or bilateral, mimicking benign conditions such as sublingual ranula. A study involving sixteen patients highlighted that thirteen cases exhibited unilateral enlargement, while three showed bilateral involvement, underscoring the variability in clinical presentation [PMID:40925827]. This swelling can be particularly problematic for patients undergoing dental implantation procedures, as it may necessitate additional interventions or delay treatment plans. For instance, the presence of such swelling can complicate the fitting and placement of dental implants, potentially requiring temporary deferral or alternative strategies to ensure successful rehabilitation [PMID:40925827]. Additionally, some patients may present with symptoms that overlap with those of a mucus retention cyst, such as a sublingual ranula, emphasizing the importance of thorough clinical evaluation to rule out benign etiologies before considering malignancy [PMID:41861582]. Early recognition of persistent or progressive swelling, especially in the context of other systemic symptoms like weight loss or pain, is crucial for timely diagnosis and intervention.
Diagnosis
Accurate diagnosis of carcinoma of the sublingual gland is pivotal for guiding appropriate treatment strategies. Clinicians often rely on a combination of clinical presentation and imaging studies to differentiate between benign and malignant causes of sublingual swelling. In a cohort study, patients were diagnosed with sublingual ranula based on clinical features and lesion characteristics, highlighting the necessity for meticulous clinical assessment to distinguish between benign and malignant conditions [PMID:41861582]. Imaging modalities such as ultrasound, CT, and MRI can provide valuable insights into the nature of the lesion, helping to identify features suggestive of malignancy, such as irregular margins, heterogeneous enhancement, or involvement of surrounding structures. Fine-needle aspiration biopsy (FNAB) or core needle biopsy may be necessary to confirm the diagnosis definitively, especially when clinical suspicion remains high despite benign appearances [PMID:40925827]. The accurate identification of malignancy is crucial for selecting minimally invasive treatments like polidocanol sclerotherapy, which has shown efficacy in managing benign sublingual lesions but requires careful consideration in suspected malignant cases [PMID:41861582].
Management
The management of carcinoma of the sublingual gland varies based on the extent of disease, patient factors, and clinician preference. Minimally invasive approaches, such as intralesional sclerotherapy with polidocanol, have demonstrated promising results in managing benign sublingual lesions, with high rates of complete resolution and minimal complications [PMID:41861582]. In a retrospective study of 34 patients treated with intralesional 3% polidocanol injection, 88.2% achieved complete resolution over a mean follow-up period of 22.44 months, with no serious adverse events reported [PMID:41861582]. However, for suspected or confirmed malignancies, surgical excision remains the gold standard due to its definitive nature and ability to achieve clear margins. Fourteen out of sixteen patients in another study required surgical excision of the enlarged sublingual gland (SLG) to facilitate dental implantation and rehabilitation, with all successfully completing their dental procedures post-surgery [PMID:40925827]. The decision to proceed with surgery should weigh the benefits of complete removal against potential risks, including functional and cosmetic outcomes. In cases where patients decline surgery, alternative strategies such as palliative care or conservative management may be considered, though these approaches often result in compromised dental rehabilitation outcomes, as evidenced by patients left with submerged implants [PMID:40925827].
Complications
The complication profile of managing carcinoma of the sublingual gland varies depending on the chosen treatment modality. Minimally invasive techniques like polidocanol sclerotherapy have been associated with a favorable safety profile, with no serious complications reported in a cohort of patients treated with this method [PMID:41861582]. This approach minimizes the risk of significant morbidity compared to surgical interventions, which carry inherent risks such as infection, bleeding, and damage to surrounding structures. However, surgical excision, while effective, can lead to complications such as postoperative swelling, infection, and functional impairments affecting speech and swallowing. Notably, patients who declined surgical removal of the enlarged SLG faced significant limitations, including the inability to proceed with prosthodontic rehabilitation, resulting in submerged dental implants and compromised oral function [PMID:40925827]. Therefore, careful patient counseling regarding the potential complications and long-term impacts of different treatment options is essential for informed decision-making.
Prognosis & Follow-up
The prognosis for patients with carcinoma of the sublingual gland is influenced by several factors, including the stage at diagnosis, extent of disease, and response to treatment. Larger lesion diameters have been independently associated with unfavorable outcomes, with an adjusted odds ratio of 0.886 per 1-mm increase in diameter, indicating that size may be a critical prognostic factor [PMID:41861582]. Patients who undergo successful surgical excision and complete dental rehabilitation tend to have positive outcomes, highlighting the importance of multidisciplinary care in achieving optimal functional and aesthetic results [PMID:40925827]. Regular follow-up is crucial to monitor for recurrence and manage any late complications. Clinicians should conduct periodic clinical examinations, imaging studies, and patient-reported outcomes to ensure sustained remission and address any emerging issues promptly. Long-term follow-up protocols should include assessments of both local disease control and functional outcomes related to speech, swallowing, and dental health, ensuring comprehensive care for these patients.
References
1 Li K, Yang X, Yu C, Zheng J, Du G, Zhou Q. Clinical Outcomes of Polidocanol Foam Sclerotherapy in Treatment of Sublingual Ranula. International dental journal 2026. link 2 Totry A, Kasem A, Slutzky I, Kablan F, Srouji S, Nahlieli O. Surgical management of the enlarged sublingual gland in mandibular posterior dental implant rehabilitation. International journal of oral and maxillofacial surgery 2026. link
2 papers cited of 3 indexed.